<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Recorded Lecture | Coughlin Lab</title><link>https://www.coughlinlab.org/tags/recorded-lecture/</link><atom:link href="https://www.coughlinlab.org/tags/recorded-lecture/index.xml" rel="self" type="application/rss+xml"/><description>Recorded Lecture</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Fri, 17 Jul 2026 16:00:00 +0000</lastBuildDate><image><url>https://www.coughlinlab.org/media/icon_hu_20f17ee5242644e8.png</url><title>Recorded Lecture</title><link>https://www.coughlinlab.org/tags/recorded-lecture/</link></image><item><title>The cost of a delayed diagnosis: Prioritizing neonatal treatment for PDE</title><link>https://www.coughlinlab.org/events/sergg_2026/</link><pubDate>Fri, 17 Jul 2026 16:00:00 +0000</pubDate><guid>https://www.coughlinlab.org/events/sergg_2026/</guid><description>&lt;p&gt;The Southeastern Regional Genetics Group (SERGG) is a non-profit 501c3 whose members include healthcare professionals involved in genetic services and newborn screening in Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, and Tennessee.&lt;/p&gt;
&lt;p&gt;One of the goals of SERGG is to address the inequities in genetic service and resources in the region and to expand existing regional capabilities and resources and to develop new regional systems to address these gaps. Another goal is to improve the existing regional communication infrastructure and to facilitate information sharing among providers of genetic services and consumers and to establish collaborative partnerships with other professional organizations.&lt;/p&gt;
&lt;div style="position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;"&gt;
&lt;iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen" loading="eager" referrerpolicy="strict-origin-when-cross-origin" src="https://www.youtube.com/embed/vEhK1TsXBco?autoplay=0&amp;amp;controls=1&amp;amp;end=0&amp;amp;loop=0&amp;amp;mute=0&amp;amp;start=0" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;" title="YouTube video"&gt;&lt;/iframe&gt;
&lt;/div&gt;</description></item><item><title>GA1: How natural history studies support the development of new treatments</title><link>https://www.coughlinlab.org/events/ga1/</link><pubDate>Wed, 25 Feb 2026 16:00:00 +0000</pubDate><guid>https://www.coughlinlab.org/events/ga1/</guid><description>&lt;h3 id="lecture-overview"&gt;Lecture overview&lt;/h3&gt;
&lt;p&gt;Dr. Coughlin provided a virtual talk on GA1. The foucsed of the talk was on natural history of GA1 including many unknown questions. We also disucssed several exciting therapeutic developments and highlighted the work of the
.&lt;/p&gt;
&lt;p&gt;The Coughlin Lab is also leading a short natural history study with the aim to support clincial trials. If interested in more information either visit our recruitment website
or contact our lab at
&lt;/p&gt;
&lt;div style="position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;"&gt;
&lt;iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen" loading="eager" referrerpolicy="strict-origin-when-cross-origin" src="https://www.youtube.com/embed/55b39XnfCWU?autoplay=0&amp;amp;controls=1&amp;amp;end=0&amp;amp;loop=0&amp;amp;mute=0&amp;amp;start=0" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;" title="YouTube video"&gt;&lt;/iframe&gt;
&lt;/div&gt;</description></item><item><title>PDE-ALDH7A1 consensus guidelines and current advances in treatment</title><link>https://www.coughlinlab.org/events/norway_2026/</link><pubDate>Wed, 11 Feb 2026 16:00:00 +0000</pubDate><guid>https://www.coughlinlab.org/events/norway_2026/</guid><description>&lt;h3 id="lecture-overview"&gt;Lecture overview&lt;/h3&gt;
&lt;p&gt;Dr. Coughlin provided a recorded (virtual) talk on PDE-ALDH7A1. Theconference includes lectures on various topics and from a number of experts on pyridoxine-dependent epliepsy. Here are a few topics and speakers:&lt;/p&gt;
&lt;p&gt;• PDE in children – Erle Kristensen
• PDE in adults - Eylert Brodtkorb
• Genetics and PDE- Toni Christoph Berger
• Sleep – Berit Hjelde-Hansen
• Diet - Cathrine Åkre Strandskogen and Kathrine Haavardsholm
• Cognitive and neuropsychiatric difficulties – Mia Tuft
• Language and alternative, supplementary communication – Silje Systad
• Legal rights – Atle Larsen&lt;/p&gt;
&lt;div style="position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;"&gt;
&lt;iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen" loading="eager" referrerpolicy="strict-origin-when-cross-origin" src="https://www.youtube.com/embed/umeXn8e36FM?autoplay=0&amp;amp;controls=1&amp;amp;end=0&amp;amp;loop=0&amp;amp;mute=0&amp;amp;start=0" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;" title="YouTube video"&gt;&lt;/iframe&gt;
&lt;/div&gt;</description></item><item><title>CRISPR Panel discussion</title><link>https://www.coughlinlab.org/events/cu_crispr/</link><pubDate>Mon, 24 Jun 2024 16:00:00 +0000</pubDate><guid>https://www.coughlinlab.org/events/cu_crispr/</guid><description>&lt;h3 id="lecture-overview"&gt;Lecture Overview&lt;/h3&gt;
&lt;p&gt;A panel discussion of the ethics surrounding CRISPR technology and its potential uses in clinical and research practices on June 24, 2024, was sponsored by the Bioethics and Humanities Student Group.&lt;/p&gt;
&lt;p&gt;Panelists: Christopher McKinney, MD, CU-SOM Hematology/Oncology and Sickle Cell Disease specialist at Children&amp;rsquo;s Hospital Colorado, Curtis R. Coughlin II, PhD, MS, MBE, CU-SOM Pediatrics, and Lindsay Brubaker, MD, CU-SOM, Gynecologic Oncology Moderated by Arjun Singh, MS1, CU School of Medicine, Class of 2027&lt;/p&gt;</description></item><item><title>Ethical Considerations for Returning Clinical Genomic Results from a Population Biobank</title><link>https://www.coughlinlab.org/events/cu_ethics_gr/</link><pubDate>Thu, 11 May 2023 16:00:00 +0000</pubDate><guid>https://www.coughlinlab.org/events/cu_ethics_gr/</guid><description>&lt;h3 id="lecture-overview"&gt;Lecture Overview&lt;/h3&gt;
&lt;p&gt;In this May 11, 2023 presentation and discussion, Christina Aquilante, PharmD, FCCP, Curtis R. Coughlin, II, PhD, MS, MBE, HEC-C, and Emily Todd, MS, CGC, described key features of the Colorado Center for Personalized Medicine biobank, identified and analyzed ethical issues associated with return of clinical pharmacogenomic results and high impact pathogenic variants from a population biobank, and addressed approaches to maximize participant benefit and autonomy in the biobank model. Moderated by Jackie Glover, PhD. Ethics Grand Rounds is co-sponsored by the CU Center for Bioethics and Humanities and UCHealth.&lt;/p&gt;
&lt;div style="position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;"&gt;
&lt;iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen" loading="eager" referrerpolicy="strict-origin-when-cross-origin" src="https://www.youtube.com/embed/Yd0WHjMVF8g?autoplay=0&amp;amp;controls=1&amp;amp;end=0&amp;amp;loop=0&amp;amp;mute=0&amp;amp;start=0" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;" title="YouTube video"&gt;&lt;/iframe&gt;
&lt;/div&gt;</description></item></channel></rss>